DARE
Dare Bioscience Inc
NASDAQ: DARE · HEALTHCARE · BIOTECHNOLOGY
$2.28
+8.57% today
Updated 2026-04-30
Market cap
$30.72M
P/E ratio
—
P/S ratio
29.82x
EPS (TTM)
$-1.20
Dividend yield
—
52W range
$1 – $3
Volume
0.4M
Dare Bioscience Inc (DARE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+44.9%
Last 4 quarters
Revenue YoY growth
-1708.4%
Most recent quarter
EPS YoY growth
+84.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+7.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+21.2%
2026-03-27
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-27 | $-0.10 | +76.0% | $1.51 | $1.83 | +21.2% |
| 2025-11-13 | $-0.28 | -1500.0% | $1.98 | $1.86 | -6.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.42 | $-0.10 | +76.0% | $1.02M | -1708.4% |
| 2025-09-30 | $0.02 | $-0.28 | -1500.0% | $2262.00 | -94.6% |
| 2025-06-30 | $0.03 | $-0.45 | -1600.0% | $-21172.00 | -194.4% |
| 2025-03-31 | $-0.58 | $-0.50 | +13.8% | $25427.00 | +173.3% |
| 2024-12-31 | $-0.63 | $-0.65 | -2.6% | $-63647.00 | -103.5% |
| 2024-09-30 | $-0.73 | $-0.55 | +24.7% | $41691.00 | -95.8% |
| 2024-06-30 | $0.02 | $-0.88 | -4500.0% | $22438.00 | — |
| 2024-03-31 | $-0.06 | $-0.07 | -16.7% | $9302.00 | — |
| 2023-12-31 | $-0.10 | $-0.06 | +40.0% | $1.81M | — |
| 2023-09-30 | $-0.10 | $-0.09 | +10.0% | $1.00M | — |
| 2023-06-30 | $-0.10 | $-0.10 | +0.0% | — | — |
| 2023-03-31 | $-0.10 | $-0.09 | +10.0% | — | — |
Frequently asked questions
Has Dare Bioscience Inc beaten earnings estimates?
Dare Bioscience Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +44.9% over the last 2 quarters.
How does DARE stock react to earnings?
DARE stock has moved an average of +7.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Dare Bioscience Inc's revenue growth rate?
Dare Bioscience Inc reported year-over-year revenue growth of -1708.4% in its most recent quarter, with EPS growing +84.5% year-over-year.